DENVER--(BUSINESS WIRE)--EvoEndo®, Inc. (“EvoEndo”), a medical device company developing systems for Unsedated Transnasal Endoscopy (TNE), has announced the receipt of 510(k) clearance from the U.S.

Building up an investment case requires looking at a stock holistically. Today I’ve chosen to put the spotlight on Technology One Limited (ASX:TNE) due to its excellent fundamentals in more than one ...

Fintel reports that on April 18, 2023, BELL POTTER SECURITIES downgraded their outlook for Technology One (ASX:TNE) from Buy to Hold. What are Other Shareholders Doing? DFAI - Dimensional ...

Transnasal esophagoscopy (TNE) is a test that helps doctors look into the esophagus and stomach. It involves passing a thin tube through the nose and down the back of the throat. A TNE allows doctors ...